|
|
|
|
LEADER |
03235nam a2200421Ia 4500 |
001 |
10.1016-j.jbc.2022.101874 |
008 |
220706s2022 CNT 000 0 und d |
020 |
|
|
|a 00219258 (ISSN)
|
245 |
1 |
0 |
|a Transcriptional coactivator PGC-1α contributes to decidualization by forming a histone-modifying complex with C/EBPβ and p300
|
260 |
|
0 |
|b American Society for Biochemistry and Molecular Biology Inc.
|c 2022
|
856 |
|
|
|z View Fulltext in Publisher
|u https://doi.org/10.1016/j.jbc.2022.101874
|
520 |
3 |
|
|a We previously reported that CCAAT/enhancer-binding protein beta (C/EBPβ) is the pioneer factor inducing transcription enhancer mark H3K27 acetylation (H3K27ac) in the promoter and enhancer regions of genes encoding insulin-like growth factor–binding protein-1 (IGFBP-1) and prolactin (PRL) and that this contributes to decidualization of human endometrial stromal cells (ESCs). Peroxisome proliferator–activated receptor gamma coactivator 1-alpha (PGC-1α; PPARGC1A) is a transcriptional coactivator known to regulate H3K27ac. However, although PGC-1α is expressed in ESCs, the potential role of PGC-1α in mediating decidualization is unclear. Here, we investigated the involvement of PGC-1α in the regulation of decidualization. We incubated ESCs with cAMP to induce decidualization and knocked down PPARGC1A to inhibit cAMP-induced expression of IGFBP-1 and PRL. We found cAMP increased the recruitment of PGC-1α and p300 to C/EBPβ-binding sites in the promoter and enhancer regions of IGFBP-1 and PRL, corresponding with increases in H3K27ac. Moreover, PGC-1α knockdown inhibited these increases, suggesting PGC-1α forms a histone-modifying complex with C/EBPβ and p300 at these regions. To further investigate the regulation of PGC-1α, we focused on C/EBPβ upstream of PGC-1α. We found cAMP increased C/EBPβ recruitment to the novel enhancer regions of PPARGC1A. Deletion of these enhancers decreased PGC-1α expression, indicating that C/EBPβ upregulates PGC-1α expression by binding to novel enhancer regions. In conclusion, PGC-1α is upregulated by C/EBPβ recruitment to novel enhancers and contributes to decidualization by forming a histone-modifying complex with C/EBPβ and p300, thereby inducing epigenomic changes in the promoters and enhancers of IGFBP-1 and PRL. © 2022 THE AUTHORS.
|
650 |
0 |
4 |
|a Acetylation
|
650 |
0 |
4 |
|a Binding sites
|
650 |
0 |
4 |
|a Binding-sites
|
650 |
0 |
4 |
|a Coactivators
|
650 |
0 |
4 |
|a Cytology
|
650 |
0 |
4 |
|a Enhancer-binding proteins
|
650 |
0 |
4 |
|a Epigenomics
|
650 |
0 |
4 |
|a Genes encoding
|
650 |
0 |
4 |
|a Insulin-like growth factor binding protein-1
|
650 |
0 |
4 |
|a Peroxisome proliferator-activated receptor
|
650 |
0 |
4 |
|a Proteins
|
650 |
0 |
4 |
|a Stromal cells
|
650 |
0 |
4 |
|a Transcription
|
650 |
0 |
4 |
|a Transcriptional co-activators
|
700 |
1 |
0 |
|a Doi-Tanaka, Y.
|e author
|
700 |
1 |
0 |
|a Fujimura, T.
|e author
|
700 |
1 |
0 |
|a Maekawa, R.
|e author
|
700 |
1 |
0 |
|a Mihara, Y.
|e author
|
700 |
1 |
0 |
|a Sato, S.
|e author
|
700 |
1 |
0 |
|a Shirafuta, Y.
|e author
|
700 |
1 |
0 |
|a Sugino, N.
|e author
|
700 |
1 |
0 |
|a Takagi, H.
|e author
|
700 |
1 |
0 |
|a Taketani, T.
|e author
|
700 |
1 |
0 |
|a Tamura, H.
|e author
|
700 |
1 |
0 |
|a Tamura, I.
|e author
|
773 |
|
|
|t Journal of Biological Chemistry
|